65214-84-8

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester
• CAS NO: 65214-84-8
• Molecular Formula: C21H25NO3
• Molecular Weight: 339.434
• Mol File: 65214-84-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester(65214-84-8)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester(65214-84-8)

Safety Data

• Hazardous Substances Data: 65214-84-8(Hazardous Substances Data)

Usage

Ethyl ester derivative

This compound is an ethyl ester, meaning it has an ethoxy group (C2H5O) attached to the piperidinecarboxylic acid.

Interaction with the central nervous system

1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester may interact with the central nervous system, which could make it a potential therapeutic agent.

Building block for the synthesis of pharmaceuticals

This compound can be used as a building block for the synthesis of other pharmaceuticals and drugs, making it a valuable tool in drug development.

Potential therapeutic applications

1-Piperidinecarboxylic acid, 4-(diphenylmethoxy)-, ethyl ester may have potential therapeutic applications, although the exact uses and efficacy may depend on the specific application and formulation.

Upstream product

• 65214-82-6 4-hydroxy-piperidine-1-carboxylic acid ethyl ester 
• 776-74-9 Bromodiphenylmethane 
• 541-41-3 chloroformic acid ethyl ester 
• 147-20-6 diphenylpyraline 

Downstream Products

• 65214-86-0 4-(diphenylmethoxy)piperidine hydrochloride 
• 770685-45-5 6-(4-Benzhydryloxy-piperidin-1-yl)-hexanoic acid methyl ester 
• 661481-71-6 5-(4-Benzhydryloxy-piperidin-1-yl)-pentanoic acid ethyl ester 
• 133016-99-6 ethyl 3-[4-(diphenylmethoxy)piperidin-1-yl]propanoate 
• 133015-42-6 ethyl <(4-diphenylmethoxy)piperidino>acetate 
• 133993-23-4 4-(4-Benzhydryloxy-piperidin-1-yl)-butyric acid 
• 125602-76-8 ethyl 4-(4-benzhydryloxypiperidino)butanoate 
• 58258-01-8 4-diphenylmethoxypiperidine 

Relevant articles and documents

Treatment of CNS disorders using CNS target modulators

The invention is directed to compositions and methods useful for treating Central Nervous System (CNS) disorders. Furthermore, the invention provides compositions and methods of treating sleep disorders. More specifically, the invention is directed to the compositions and use of derivatized, histamine antagonists for the treatment of sleep disorders.

Triazolo and derivatives as chemokine inhibitors

Novel triazolo derivatives represented by the following formula and pharmaceutically acceptable salts thereof, as well as chemokine inhibitors containing the same as an effective component. These are useful as therapeutic agents for allergic diseases such

1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives

Novel 1-[(heterocyclyl)alkyl]-4-diarylmethoxy piperidine derivatives are disclosed having the formula STR1 where n is 2-6, Ar1 and Ar2 are aryl and B is a substituted benzimidazolyl radical. These compounds are useful for their antianaphylactic and antihistaminic properties. Specific claimed compounds are 1-{3-[4-(diphenylmethoxy)-1-piperidinyl]-propyl}-1,3-dihydro-2H-benzimidazol-2-one, 1-{2-[4-(diphenylmethoxy)-1-piperidinyl]ethyl}1-, 3-dihydro-2H-benzimidazol-2-one, and 1-{4-[4-(diphenylmethoxy)-1-piperidinyl]butyl}-1,3-dihydro-2H-benzimidazol-2-one.